CY1107417T1 - Νεοι σταθεροι κρυσταλλοι υποκατεστημενου παραγωγου φαινυλοπροπιονικου οξεος και μεθοδος δια την παραγωγη αυτου - Google Patents
Νεοι σταθεροι κρυσταλλοι υποκατεστημενου παραγωγου φαινυλοπροπιονικου οξεος και μεθοδος δια την παραγωγη αυτουInfo
- Publication number
- CY1107417T1 CY1107417T1 CY20081100446T CY081100446T CY1107417T1 CY 1107417 T1 CY1107417 T1 CY 1107417T1 CY 20081100446 T CY20081100446 T CY 20081100446T CY 081100446 T CY081100446 T CY 081100446T CY 1107417 T1 CY1107417 T1 CY 1107417T1
- Authority
- CY
- Cyprus
- Prior art keywords
- phynylpropynic
- substituted
- producing
- acid production
- new stable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/22—Separation; Purification; Stabilisation; Use of additives
- C07C231/24—Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/58—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/60—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring with carbon atoms of carboxamide groups and singly-bound oxygen atoms, bound in ortho-position to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Παρασκευή (S)- 2- [[3- [Ν- [4-[(4- φθοριοφαινόξυ) μεθύλ] καρβαμοϋλ]- 4- μεθοξυφαινύλ] μεθύλ] βουτανοϊκού οξέος (αναφέρεται επίσης και ως ένωση (ι)) σε βιομηχανική κλίμακα βασίζεται στην ανεύρεση κρυστάλλων ομοιογενών και εξαιρετικής σταθερότητος και εις την διαμόρφωση μιας παρασκευαστικής μεθόδου δια αυτήν. Νέοι κρύσταλλοι της ενώσεως (I) ομοιογενείς και εξαιρετικής σταθερότητος χαρακτηριζόμενοι από παρουσίαση γωνιών περιθλάσεως (2θ) εις τουλάχιστον 17.7°, 19.0° και 24.1° εις την περίθλαση πούδρας με ακτίνες - Χ παρασκευάζονται δια ανακρυσταλλώσεως από έναν αλκοολικό διαλύτη και δια καθαρισμού δια οξίνης βασικής κατεργασίας.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001377077 | 2001-12-11 | ||
EP02783815A EP1462439B1 (en) | 2001-12-11 | 2002-12-10 | Novel stable crystals of substituted phenylpropionic acid derivative and process for producing the same |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1107417T1 true CY1107417T1 (el) | 2012-12-19 |
Family
ID=19185129
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20081100446T CY1107417T1 (el) | 2001-12-11 | 2008-04-21 | Νεοι σταθεροι κρυσταλλοι υποκατεστημενου παραγωγου φαινυλοπροπιονικου οξεος και μεθοδος δια την παραγωγη αυτου |
Country Status (14)
Country | Link |
---|---|
US (1) | US7279596B2 (el) |
EP (1) | EP1462439B1 (el) |
JP (1) | JP4424728B2 (el) |
KR (1) | KR100876849B1 (el) |
CN (1) | CN1312121C (el) |
AT (1) | ATE390406T1 (el) |
AU (1) | AU2002349538B2 (el) |
CA (1) | CA2469882C (el) |
CY (1) | CY1107417T1 (el) |
DE (1) | DE60225841T2 (el) |
DK (1) | DK1462439T3 (el) |
ES (1) | ES2302857T3 (el) |
PT (1) | PT1462439E (el) |
WO (1) | WO2003050077A1 (el) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0515015A (pt) | 2004-08-11 | 2008-07-01 | Kyorin Seiyaku Kk | derivado cìclico de ácido aminobenzóico; medicamento; agonista ppar(alpha); agonista duplo ppar(alpha), y; agonista duplo ppar(alpha), (delta); modulador ppar; agente lipìdeo; agente profilático ou terapêutico compreendendo pelo menos um dos derivados cìclicos de ácido aminobenzóico ou sal do mesmo farmacêuticamente aceitável |
JP2007001912A (ja) * | 2005-06-22 | 2007-01-11 | Univ Of Tokyo | 置換フェニルプロピオン酸誘導体 |
CA2669849C (en) * | 2006-12-06 | 2012-01-31 | Pfizer Inc. | Crystalline forms of (3s)-3-[n-(n'-(2-tert-butylphenyl)oxamyl)alaninyl]amino-5-(2',3',5',6'-tetrafluorophenoxy)-4-oxopentanoic acid |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4618845B2 (ja) * | 1999-06-09 | 2011-01-26 | 杏林製薬株式会社 | ヒトペルオキシゾーム増殖薬活性化受容体(PPAR)αアゴニストとしての置換フェニルプロピオン酸誘導体 |
EP1219595B1 (en) * | 1999-09-17 | 2006-01-18 | Kyorin Pharmaceutical Co., Ltd. | O-anisamide derivatives |
TWI262185B (en) * | 1999-10-01 | 2006-09-21 | Eisai Co Ltd | Carboxylic acid derivatives having anti-hyperglycemia and anti-hyperlipemia action, and pharmaceutical composition containing the derivatives |
-
2002
- 2002-12-10 DK DK02783815T patent/DK1462439T3/da active
- 2002-12-10 DE DE60225841T patent/DE60225841T2/de not_active Expired - Lifetime
- 2002-12-10 PT PT02783815T patent/PT1462439E/pt unknown
- 2002-12-10 US US10/497,174 patent/US7279596B2/en not_active Expired - Fee Related
- 2002-12-10 JP JP2003551104A patent/JP4424728B2/ja not_active Expired - Fee Related
- 2002-12-10 CA CA002469882A patent/CA2469882C/en not_active Expired - Fee Related
- 2002-12-10 AU AU2002349538A patent/AU2002349538B2/en not_active Ceased
- 2002-12-10 CN CNB028245946A patent/CN1312121C/zh not_active Expired - Fee Related
- 2002-12-10 AT AT02783815T patent/ATE390406T1/de active
- 2002-12-10 KR KR1020047008935A patent/KR100876849B1/ko not_active IP Right Cessation
- 2002-12-10 EP EP02783815A patent/EP1462439B1/en not_active Expired - Lifetime
- 2002-12-10 WO PCT/JP2002/012892 patent/WO2003050077A1/ja active IP Right Grant
- 2002-12-10 ES ES02783815T patent/ES2302857T3/es not_active Expired - Lifetime
-
2008
- 2008-04-21 CY CY20081100446T patent/CY1107417T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
US20050228050A1 (en) | 2005-10-13 |
ATE390406T1 (de) | 2008-04-15 |
AU2002349538A1 (en) | 2003-06-23 |
EP1462439A1 (en) | 2004-09-29 |
KR20040075000A (ko) | 2004-08-26 |
AU2002349538B2 (en) | 2006-04-27 |
CA2469882C (en) | 2009-09-29 |
US7279596B2 (en) | 2007-10-09 |
DE60225841D1 (de) | 2008-05-08 |
CA2469882A1 (en) | 2003-06-19 |
EP1462439B1 (en) | 2008-03-26 |
DK1462439T3 (da) | 2008-04-21 |
CN1602295A (zh) | 2005-03-30 |
CN1312121C (zh) | 2007-04-25 |
ES2302857T3 (es) | 2008-08-01 |
EP1462439A4 (en) | 2006-02-01 |
DE60225841T2 (de) | 2009-05-14 |
WO2003050077A1 (fr) | 2003-06-19 |
PT1462439E (pt) | 2008-04-10 |
JP4424728B2 (ja) | 2010-03-03 |
JPWO2003050077A1 (ja) | 2005-04-21 |
KR100876849B1 (ko) | 2008-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3023422B2 (ja) | ヘモグロビンのアロステリック修飾剤 | |
EE200200441A (et) | 2-arüülpropioonhappe amiidide R-enantiomeerid, nende valmistamismeetod, farmatseutiline kompositsioon ja 2-arüülpropioonhapete R-enantiomeerid | |
HUP0301661A2 (hu) | Bifenil-karboxamidok, intermedierjeik, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó mikrobicid készítmények | |
Krátký et al. | Antifungal activity of salicylanilides and their esters with 4-(trifluoromethyl) benzoic acid | |
CY1113873T1 (el) | Παραγωγα hydroxybenzamide σαν παραγοντες καταστολης της hsp90 | |
CA2493794A1 (en) | Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile | |
CY1107417T1 (el) | Νεοι σταθεροι κρυσταλλοι υποκατεστημενου παραγωγου φαινυλοπροπιονικου οξεος και μεθοδος δια την παραγωγη αυτου | |
EA200701687A1 (ru) | Гидрохлорид аморфного лерканидипина | |
EA200400140A1 (ru) | Пероральные противодиабетические агенты | |
TW200722415A (en) | New process | |
Tugrak et al. | Synthesis and anticancer properties of mono Mannich bases containing vanillin moiety | |
NO20045497L (no) | Fremgangsmate for fremstilling av 5-(1,3-oksazol-2-yl)benzosyrederivater | |
CY1107112T1 (el) | Κρυσταλλοι τοζιλικου suplatast | |
EA199900217A1 (ru) | Стабильная негигроскопичная кристаллическая форма n-[n-n-(4-(пиперидин-4-ил)бутаноил)-n-этилглицилового] соединения | |
BRPI0520433A2 (pt) | sais farmaceuticamente aceitáveis de 2,4,6-trimetil-3-hidroxipiridina, com ácidos dicarboxìlicos inferiores e método para preparação dos mesmos | |
RU2012139082A (ru) | Способы получения производных циклопропиламида и связанных с ними промежуточных соединений | |
NO20082005L (no) | Syntese av renininhibitorer omfattende en cyklotilfoyelsesreaksjon | |
EA200201055A1 (ru) | Новый стабильный кристалл производного тиазолидиндиона и способ его получения | |
RU2008100036A (ru) | Кристаллические формы производного пирролотриазина | |
ITRM20010729A1 (it) | Sale di acetil l-carnitina con un acido organico dicarbossilico e procedimento per la sua preparazione. | |
DK0947499T3 (da) | Fremgangsmåde til fremstilling af racemisk sertralin | |
Tarikogullari et al. | Synthesis and anticonvulsant activity of some alkanamide derivatives | |
ATE374193T1 (de) | R-2-(aminoaryl)-propionsäure-amide und ihre verwendung zur aktivierung von leukocyten | |
DE60213958D1 (de) | Aryl-n-cyanoguanidine derivate und deren verwendung | |
Ienaşcu et al. | Synthesis and characterization of some new 5-bromo-2-hydroxy-benzamide derivatives |